The trademark application REVOW was filed by Eli Lilly and Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on May 13, 2007, and it was registered by office on November 21, 2007 without any oppositions.
The application was filed in English (Italian was selected as the second language).
The renewal of the trademark was recorded by the office on November 22, 2016.
Change of name and professional address of the trademark registration was recorded on December 19, 2018. Appointment and Replacement of representative of the trademark registration was recorded on April 16, 2019.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, diabetic neuropathy, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive system diseases and disorders, sexual dysfunction, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders
Pharmaceutical preparations for the prevention of diabetes